Cardioloxía
Servizo
Fundación Jiménez Díaz
Madrid, EspañaPublicacións en colaboración con investigadores/as de Fundación Jiménez Díaz (54)
2024
-
Symptom burden guiding invasive electrophysiological study in paroxysmal supraventricular tachycardia: The believe SVT registry
American Heart Journal, Vol. 269, pp. 15-24
2023
-
Bleeding and embolic risk in patients with atrial fibrillation and cancer
Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 344-352
-
Spontaneous Variation of Ventriculo-Atrial Interval after Tachycardia Induction: Determinants and Usefulness in the Diagnosis of Supraventricular Tachycardias with Long Ventriculoatrial Interval
Journal of Clinical Medicine, Vol. 12, Núm. 2
2022
-
An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease
Molecular Genetics and Metabolism, Vol. 137, Núm. 1-2, pp. 49-61
-
Analysis of the management of ST-segment elevation myocardial infarction in Spain. Results from the ACI-SEC Infarction Code Registry
Revista Espanola de Cardiologia, Vol. 75, Núm. 8, pp. 669-680
-
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up
European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412
-
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058
-
Nutrition status, obesity and outcomes in patients with atrial fibrillation
Revista Espanola de Cardiologia, Vol. 75, Núm. 10, pp. 826-833
-
Procedural Results and One-Year Clinical Outcomes of Treatment of Bioresorbable Vascular Scaffolds Restenosis (from the RIBS VII Prospective Study)
American Journal of Cardiology, Vol. 162, pp. 31-40
-
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588
-
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301
-
Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort
International Journal of Cardiology, Vol. 367, pp. 90-98
-
Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation
Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 334-342
2021
-
Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI)
Basic Research in Cardiology, Vol. 116, Núm. 1
-
Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes
Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791
-
In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients
EuroIntervention, Vol. 16, Núm. 17, pp. 1426-1433
-
Mitral valve prolapse morphofunctional features by cardiovascular magnetic resonance: more than just a valvular disease
Journal of Cardiovascular Magnetic Resonance, Vol. 23, Núm. 1
-
Outcomes of nonagenarians after transcatheter aortic valve implantation
REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 250-257
-
Stratification and management of cardiovascular risk in cancer patients. A consensus document of the SEC, FEC, SEOM, SEOR, SEHH, SEMG, AEEMT, AEEC, and AECC
Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 438-448